Permissive central tolerance plus defective peripheral checkpoints license pathogenic memory B cells in CASPR2-antibody encephalitis
Open Access
- 18 April 2025
- journal article
- immunology
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (16) , eadr9986
Abstract
Autoantibody-mediated diseases targeting one autoantigen provide a unique opportunity to comprehensively understand the development of disease-causing B cells and autoantibodies. Convention suggests that such autoreactivities are generated during germinal center reactions. Here, we explore earlier immune checkpoints, focusing on patients with contactin-associated protein-like 2 (CASPR2)–autoantibody encephalitis. In both disease and health, high (~0.5%) frequencies of unmutated CASPR2-reactive naïve B cells were identified. By contrast, CASPR2-reactive memory B cells were exclusive to patients, and their B cell receptors demonstrated affinity-enhancing somatic mutations with pathogenic effects in neuronal cultures and mice. The unmutated, precursor memory B cell receptors showed a distinctive balance between strong CASPR2 reactivity and very limited binding across the remaining human proteome. Our results identify permissive central tolerance, defective peripheral tolerance, and autoantigen-specific tolerance thresholds in humans as sequential steps that license CASPR2-directed pathology. By leveraging the basic immunobiology, we rationally direct tolerance-restoring approaches, with an experimental paradigm applicable across autoimmunity.Keywords
This publication has 51 references indexed in Scilit:
- PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritisJournal of Autoimmunity, 2013
- Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cellsBlood, 2013
- Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interfaceJournal of Clinical Investigation, 2012
- Morvan syndrome: Clinical and serological observations in 29 casesAnnals of Neurology, 2012
- Autoantigen discovery with a synthetic human peptidomeNature Biotechnology, 2011
- Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotoniaBrain, 2010
- Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloningJournal of Immunological Methods, 2008
- Predominant Autoantibody Production by Early Human B Cell PrecursorsScience, 2003
- Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells.Journal of Clinical Investigation, 1997
- The human immunoglobulin VH repertoireImmunology Today, 1995